Approval · Notice of Compliance 34034 · 2024
INFLECTRA: Notice of Compliance 34034
Issued September 4, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34034
- Date
- September 4, 2024
- Company
- Celltrion Inc.Incheon, Korea, Republic Of
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative - Change in Product Ownership
- Canadian reference product
- REMICADE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INFLECTRA | 02419475 | Marketed |
Medicinal ingredients
- INFLIXIMAB 100 MG per VIAL